147 related articles for article (PubMed ID: 1371232)
1. Primary treatment of pelvic osteosarcoma. Report of five cases.
Estrada-Aguilar J; Greenberg H; Walling A; Schroer K; Black T; Morse S; Hvizdala E
Cancer; 1992 Mar; 69(5):1137-45. PubMed ID: 1371232
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
[TBL] [Abstract][Full Text] [Related]
3. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
4. Systemic doxorubicin and intraarterial cisplatin preoperative chemotherapy plus postoperative adjuvant chemotherapy in patients with osteosarcoma.
Stine KC; Hockenberry MJ; Harrelson J; Miner D; Falletta JM
Cancer; 1989 Mar; 63(5):848-53. PubMed ID: 2914292
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
[No Abstract] [Full Text] [Related]
6. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
7. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD
Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612
[TBL] [Abstract][Full Text] [Related]
8. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
Cassano WF; Graham-Pole J; Dickson N
Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
[TBL] [Abstract][Full Text] [Related]
9. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Delepine N; Delepine G; Desbois JC
Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
[No Abstract] [Full Text] [Related]
10. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
11. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
12. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
13. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
15. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2.
Meazza C; Cefalo G; Massimino M; Daolio P; Pastorino U; Scanagatta P; Morosi C; Podda M; Ferrari A; Terenziani M; Spreafico F; Casanova M; Parafioriti A; Collini P; Gandola L; Bastoni S; Biassoni V; Schiavello E; Chiaravalli S; Puma N; Bergamaschi L; Luksch R
Med Oncol; 2017 Nov; 34(12):191. PubMed ID: 29094224
[TBL] [Abstract][Full Text] [Related]
16. Palliative treatment for advanced or metastatic osteosarcoma.
Merimsky O; Kollender Y; Inbar M; Meller I; Bickels J
Isr Med Assoc J; 2004 Jan; 6(1):34-8. PubMed ID: 14740508
[No Abstract] [Full Text] [Related]
17. Treatment of pelvic osteosarcoma.
Marangolo M; Tienghi A; Fiorentini G; Dazzi C; Graziani G; Priori T; Emiliani E
Ann Oncol; 1992 Apr; 3 Suppl 2():S19-21. PubMed ID: 1622857
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Mahajan A; Woo SY; Kornguth DG; Hughes D; Huh W; Chang EL; Herzog CE; Pelloski CE; Anderson P
Pediatr Blood Cancer; 2008 May; 50(5):976-82. PubMed ID: 18213710
[TBL] [Abstract][Full Text] [Related]
19. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
